Search

Your search keyword '"Lars Bullinger"' showing total 254 results

Search Constraints

Start Over You searched for: Author "Lars Bullinger" Remove constraint Author: "Lars Bullinger" Topic biology Remove constraint Topic: biology
254 results on '"Lars Bullinger"'

Search Results

1. The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements

2. Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9

3. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

4. Deregulated expression of circular RNAs in acute myeloid leukemia

5. Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication

6. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms

7. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers

9. Single-cell analysis based dissection of clonality in myelofibrosis

10. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal

11. CYTIDINE DEAMINASES SHAPE THE GENOME OF GERMINAL CENTER B CELL DERIVED LYMPHOMA

12. Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation

13. Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

14. Genomic Landscape and Clonal Evolution of AML

15. Does RAD21 Co-Mutation Have a Role in DNMT3A Mutated AML? Results of Harmony Alliance AML Database

16. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients

17. Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription

18. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas

19. RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia

20. The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell function

21. Expression of <scp>CD</scp> 274 ( <scp>PD</scp> ‐L1) is associated with unfavourable recurrent mutations in <scp>AML</scp>

22. Single-Cell Clonal Tracking in Allogeneic Hematopoietic Stem Cell Transplantation Reveals Time Dependent and Distinct Functional Patterns in Traceable Donor T Cell Clones

23. Easix Predicts Severe Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neuro-Toxicity Syndrome (ICANS) in Patients Receiving CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy

24. Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype

25. Protein phosphatase 4 regulatory subunit 2 (PPP4R2) is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repair

26. Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation

27. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways

28. Identifying ischemic stroke associated with cancer: a multiple model derived from a case–control analysis

29. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia

30. FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells

31. Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)

32. IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia

33. Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML

34. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML

35. Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers

36. Aberrant expression of miR-9/9*in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG

37. Expression of a passenger miR-9*predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age

38. Integration of Hi-C and Nanopore Sequencing for Structural Variant Analysis in AML with a Complex Karyotype: (Chromothripsis)²

39. Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells

40. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients

41. Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

42. Circular RNAs in Cancer

43. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs

44. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia

45. Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens

46. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)

47. Cellular origin of prognostic chromosomal aberrations in AML patients

48. Telomerase Inhibition Effectively Targets Mouse and Human AML Stem Cells and Delays Relapse following Chemotherapy

49. MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses

50. MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences

Catalog

Books, media, physical & digital resources